Sympti
PrivateLast Round
Accelerator
Dec 17, 2020
Total Funding Raised
$150,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sympti is a healthtech company that provides an artificial intelligence-driven medical service platform for patients to find and book urgent care, emergency rooms, and telehealth visits.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Medical AI, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympti Comparables
Compare Sympti with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clearstep | 86% | |
| DexCare | 78% | |
| Infermedica | 78% |
Sympti Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 17, 2020 | ||||
| Accelerator | Jun 5, 2018 |
Sympti Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quake Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM.
- Jul 29, 2026
Monthly visitors grew 73% MoM.
Sympti Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sympti's valuation, stock price, and market status.
Is Sympti a public or private company?
Sympti is a private company.
What is the current stock price of Sympti?
Sympti is a private company with no public stock price. No recent secondary market data is available.
How much is Sympti worth (valuation)?
Valuation information for Sympti is not publicly available.
Can I buy Sympti stock?
Sympti shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sympti's last funding round?
Sympti's most recent funding round was Accelerator on June 5, 2018.
Who are the main investors in Sympti?
Key investors in Sympti include Quake Capital.
Will Sympti IPO soon?
No public IPO plans have been announced for Sympti.
How can I track Sympti secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sympti's secondary market activity and sign up for updates.